Medivation Recent News
Short Interest Surges In Illumina And Vertex Pharmaceuticals
Short Sellers Dump Amgen And Baxalta
Here's What Medivation Said In Its Rejection Letter To Sanofi
Sanofi Wants To Acquire Medivation For $52.50 Per Share
Short Sellers Dump Vertex, Load Up On Baxalta
Medivation Ticks Up 3%, AstraZeneca Said To Be Also Interested In Acquisition
Medivation Drops 12% After Congress Asks To Examine Xtandi Drug Price
More Wild Short Interest Swings In Biotech Stocks
Wild Short Interest Swings For Three Top Biotech Stocks
3 Biotech Stocks With Rising Short Interest
Citigroup Adds Tesaro To 'Focus List,' Removes Medivation
3 More Surges In Biotech Short Interest (AMGN, MDVN, PCYC)
Surges In Biotech Short Interest (INCY, PCYC, REGN)
Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)
Celgene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)
BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)
Market Wrap For February 28: Markets Unable To Hold On To Gains
Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, BMRN)
BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)
New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)
Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)
Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)
Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)